Literature DB >> 23219913

Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.

Nicole M Chapman1, Mahmood Y Bilal, Noemi Cruz-Orcutt, Cory Knudson, Sofia Madinaveitia, Jonathan Light, Jon C D Houtman.   

Abstract

Toll-like receptor 2 (TLR2) serves as a co-stimulatory receptor for human T cells by enhancing T cell receptor (TCR)-induced cytokine production and proliferation. However, it is unknown where signals from the TCR and TLR2 converge to enhance T cell activation. To address this gap, we examined changes in TCR-induced signaling following concurrent TLR2 activation in human T cells. Both proximal TCR-mediated signaling and early NFκB activation were not enhanced by TCR and TLR2 co-activation, potentially due to the association of TLR2 with TLR10. Instead, TLR2 co-induction did augment Akt and Erk1/Erk2 activation in human T cells. These findings demonstrate that TLR2 activates distinct signaling pathways in human T cells and suggest that alterations in expression of TLR2 co-receptors may contribute to aberrant T cell responses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219913      PMCID: PMC3883577          DOI: 10.1016/j.cellsig.2012.11.026

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  73 in total

1.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

2.  TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.

Authors:  Blandine C Mercier; Anne Cottalorda; Charles-Antoine Coupet; Jacqueline Marvel; Nathalie Bonnefoy-Bérard
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 3.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

Review 4.  Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases.

Authors:  Sinead C Corr; Luke A J O'Neill
Journal:  J Innate Immun       Date:  2009-02-11       Impact factor: 7.349

5.  TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation.

Authors:  Anne Cottalorda; Claire Verschelde; Antoine Marçais; Martine Tomkowiak; Philippe Musette; Satoshi Uematsu; Shizuo Akira; Jacqueline Marvel; Nathalie Bonnefoy-Berard
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

Review 6.  TLR-dependent T cell activation in autoimmunity.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2011-11-18       Impact factor: 53.106

Review 7.  Toll-like receptor signalling on Tregs: to suppress or not to suppress?

Authors:  Wendy W C van Maren; Joannes F M Jacobs; I Jolanda M de Vries; Stefan Nierkens; Gosse J Adema
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

8.  A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.

Authors:  Michael Quigley; Jennifer Martinez; Xiaopei Huang; Yiping Yang
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

9.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

10.  Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.

Authors:  Andrew N Macintyre; David Finlay; Gavin Preston; Linda V Sinclair; Caryll M Waugh; Peter Tamas; Carmen Feijoo; Klaus Okkenhaug; Doreen A Cantrell
Journal:  Immunity       Date:  2011-02-03       Impact factor: 31.745

View more
  10 in total

1.  Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.

Authors:  Mikaela M Tremblay; Mahmood Y Bilal; Jon C D Houtman
Journal:  Mol Immunol       Date:  2013-10-12       Impact factor: 4.407

2.  FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells.

Authors:  Anil K Chauhan
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

3.  Proline-rich tyrosine kinase 2 controls PI3-kinase activation downstream of the T cell antigen receptor in human T cells.

Authors:  Nicole M Chapman; Ashley N Yoder; Kathryn M Barbón; Mahmood Y Bilal; Sean F Connolly; Jon C D Houtman
Journal:  J Leukoc Biol       Date:  2014-11-11       Impact factor: 4.962

4.  TCR-mediated functions are enhanced in activated peripheral blood T cells isolated from leucocyte reduction systems.

Authors:  Mikaela M Tremblay; Jon C D Houtman
Journal:  J Immunol Methods       Date:  2014-11-25       Impact factor: 2.303

Review 5.  Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.

Authors:  Emily R Mercadante; Ulrike M Lorenz
Journal:  Front Immunol       Date:  2016-05-18       Impact factor: 7.561

6.  Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.

Authors:  Erica C Larson; Camille L Novis; Laura J Martins; Amanda B Macedo; Kadyn E Kimball; Alberto Bosque; Vicente Planelles; Louis R Barrows
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

Review 7.  Gene modification strategies for next-generation CAR T cells against solid cancers.

Authors:  Yonggui Tian; Yilu Li; Yupei Shao; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-05-18       Impact factor: 17.388

Review 8.  T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells.

Authors:  Yasmin Nouri; Robert Weinkove; Rachel Perret
Journal:  J Immunother Cancer       Date:  2021-11       Impact factor: 13.751

Review 9.  Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease.

Authors:  Jun Shimizu; Fumio Kaneko; Noboru Suzuki
Journal:  Genet Res Int       Date:  2013-12-30

10.  Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE).

Authors:  Philip George; Nathaniel Dasyam; Giulia Giunti; Brigitta Mester; Evelyn Bauer; Bethany Andrews; Travis Perera; Tess Ostapowicz; Chris Frampton; Peng Li; David Ritchie; Catherine M Bollard; Ian F Hermans; Robert Weinkove
Journal:  BMJ Open       Date:  2020-02-09       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.